BriaCell Announces Participation at the 21st Annual Global Investment Conference in New York City September 8-10, 2019

BriaCell Therapeutics Corp. (“BriaCell” or the “Company”) (BCT.V) (BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast cancer, today announced it will be featured…… Read more “BriaCell Announces Participation at the 21st Annual Global Investment Conference in New York City September 8-10, 2019”